F. Harrell, R. Califf, D. Pryor, K. Lee, R. Rosati (1982)
Evaluating the yield of medical tests.JAMA, 247 18
M. Aidoo, V. Udhayakumar (2000)
Field studies of cytotoxic T lymphocytes in malaria infections: implications for malaria vaccine development.Parasitology today, 16 2
JA Stoute (1997)
A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malariaN. Engl. J. Med., 336
K. Flanagan, Edwin Lee, M. Gravenor, W. Reece, B. Urban, T. Doherty, K. Bojang, M. Pinder, A. Hill, M. Plebanski (2001)
Unique T Cell Effector Functions Elicited by Plasmodium falciparum Epitopes in Malaria-Exposed Africans Tested by Three T Cell Assays1The Journal of Immunology, 167
Eleanor Riley, Stephen Allen, Stephen Bennett, P. Thomas, Angela O'Donnell, Steve Lindsay, Michael Good, Brian Greenwood (1990)
Recognition of dominant T cell-stimulating epitopes from the circumsporozoite protein of Plasmodium falciparum and relationship to malaria morbidity in Gambian children.Transactions of the Royal Society of Tropical Medicine and Hygiene, 84 5
P. Romero, J. Maryanski, G. Corradin, R. Nussenzweig, V. Nussenzweig, F. Zavala (1989)
Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malariaNature, 341
S. Polley, K. Tetteh, D. Cavanagh, R. Pearce, J. Lloyd, K. Bojang, D. Okenu, B. Greenwood, J. McBride, D. Conway (2003)
Repeat Sequences in Block 2 of Plasmodium falciparum Merozoite Surface Protein 1 Are Targets of Antibodies Associated with Protection from MalariaInfection and Immunity, 71
V. Baron, C. Bouneaud, A. Cumano, A. Lim, T. Arstila, P. Kourilsky, L. Ferradini, C. Pannetier (2003)
The repertoires of circulating human CD8(+) central and effector memory T cell subsets are largely distinct.Immunity, 18 2
F. Sinigaglia, M. Guttinger, D. Gillessen, D. Doran, B. Takács, H. Matile, A. Trzeciak, J. Pink (1988)
Epitopes recognized by human t lymphocytes on malaria circumsporozoite proteinEuropean Journal of Immunology, 18
Fidel Zavala, James Tam, Philip Barr, Pedro Romero, Victoria Ley, R. Nussenzweig, Victor Nussenzweig (1987)
Synthetic peptide vaccine confers protection against murine malariaThe Journal of Experimental Medicine, 166
S. Hoffman, C. Oster, Carl Mason, John Beier, James Sherwood, Ballou Wr, Mutuma Mugambi, J. Chulay (1989)
Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria.Journal of immunology, 142 4
S. McConkey, W. Reece, V. Moorthy, D. Webster, Susanna Dunachie, G. Butcher, J. Vuola, T. Blanchard, P. Gothard, K. Watkins, C. Hannan, S. Everaere, K. Brown, K. Kester, J. Cummings, Jackie Williams, D. Heppner, A. Pathan, K. Flanagan, N. Arulanantham, M. Roberts, M. Roy, Geoffrey Smith, J. Schneider, T. Peto, R. Sinden, S. Gilbert, A. Hill (2003)
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humansNature Medicine, 9
Francesco Sinigaglia, M. Guttinger, J. Kilgus, D. Doran, Hugues Matile, H. Etlinger, A. Trzeciak, D. Gillessen, J. Pink (1988)
A malaria T-cell epitope recognized in association with most mouse and human MHC class II moleculesNature, 336
K. Bojang, P. Milligan, M. Pinder, L. Vigneron, A. Alloueche, K. Kester, W. Ballou, D. Conway, W. Reece, P. Gothard, L. Yamuah, M. Delchambre, G. Voss, B. Greenwood, A. Hill, K. McAdam, N. Tornieporth, Joe Cohen, T. Doherty (2001)
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trialThe Lancet, 358
A. Lalvani, Phillipe Moris, G. Voss, A. Pathan, K. Kester, Roger Brookes, Edwin Lee, M. Koutsoukos, Magdalena Plebanski, M. Delchambre, Katie L. Flanagan, Cecile Carton, Moncef Slaoui, Christian Van Hoecke, W. Ballou, Adrian V. S. Hill, Joe Cohen (1999)
Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.The Journal of infectious diseases, 180 5
F. Sallusto, D. Lenig, R. Förster, M. Lipp, A. Lanzavecchia (1999)
Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 401
K. Flanagan, T. Mwangi, M. Plebanski, Kennedy Odhiambo, A. Ross, E. Sheu, M. Kortok, B. Lowe, K. Marsh, A. Hill (2003)
Ex vivo interferon-gamma immune response to thrombospondin-related adhesive protein in coastal Kenyans: longevity and risk of Plasmodium falciparum infection.The American journal of tropical medicine and hygiene, 68 4
J. Stoute, M. Slaoui, D. Heppner, P. Momin, K. Kester, P. Desmons, B. Wellde, N. Garçon, U. Krzych, M. Marchand, W. Ballou, Joe Cohen (1997)
A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.The New England journal of medicine, 336 2
K. Kester, Denise Mckinney, N. Tornieporth, C. Ockenhouse, D. Heppner, T. Hall, U. Krzych, M. Delchambre, G. Voss, M. Dowler, J. Palensky, J. Wittes, J. Cohen, W. Ballou (2001)
Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria.The Journal of infectious diseases, 183 4
A. Godkin, H. Thomas, P. Openshaw (2002)
Evolution of Epitope-Specific Memory CD4+ T Cells After Clearance of Hepatitis C VirusThe Journal of Immunology, 169
Peter Bull, B. Lowe, M. Kortok, C. Molyneux, C. Newbold, K. Marsh (1998)
Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malariaNature Medicine, 4
J. Stoute, K. Kester, U. Krzych, B. Wellde, T. Hall, K. White, G. Glenn, C. Ockenhouse, N. Garçon, R. Schwenk, D. Lanar, Peifang Sun, P. Momin, R. Wirtz, C. Golenda, M. Slaoui, G. Wortmann, C. Holland, M. Dowler, Joe Cohen, W. Ballou (1998)
Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine.The Journal of infectious diseases, 178 4
Chang‐you Wu, J. Kirman, M. Rotte, Dylan Davey, S. Perfetto, Elizabeth Rhee, Brenda Freidag, Brenna Hill, D. Douek, R. Seder (2002)
Distinct lineages of TH1 cells have differential capacities for memory cell generation in vivoNature Immunology, 3
E. Wherry, V. Teichgräber, Todd Becker, D. Masopust, S. Kaech, R. Antia, U. Andrian, R. Ahmed (2003)
Lineage relationship and protective immunity of memory CD8 T cell subsetsNature Immunology, 4
A. Alloueche, P. Milligan, D. Conway, M. Pinder, K. Bojang, T. Doherty, N. Tornieporth, Joe Cohen, B. Greenwood (2003)
Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific.The American journal of tropical medicine and hygiene, 68 1
B. Wizel, R. Houghten, Kenneth Parker, J. Coligan, Preston Church, Daniel Gordon, W Ballou, Stephen Hoffman (1995)
Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2The Journal of Experimental Medicine, 182
R. Schwenk, L. Asher, Isaac Chalom, D. Lanar, Peifang Sun, K. White, D. Keil, K. Kester, J. Stoute, D. Heppner, U. Krzych (2003)
Opsonization by antigen‐specific antibodies as a mechanism of protective immunity induced by Plasmodium falciparum circumsporozoite protein‐based vaccineParasite Immunology, 25
Peifang Sun, R. Schwenk, K. White, J. Stoute, Joe Cohen, W. Ballou, G. Voss, K. Kester, D. Heppner, U. Krzych (2003)
Protective Immunity Induced with Malaria Vaccine, RTS,S, Is Linked to Plasmodium falciparum Circumsporozoite Protein-Specific CD4+ and CD8+ T Cells Producing IFN-γ1The Journal of Immunology, 171
M. Pinder, W. Reece, M. Plebanski, P. Akinwunmi, K. Flanagan, Edwin Lee, T. Doherty, P. Milligan, A. Jaye, N. Tornieporth, R. Ballou, K. McAdam, Joe Cohen, A. Hill (2004)
Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi‐immune adults in The GambiaClinical & Experimental Immunology, 135
Renjie Wang, Y. Charoenvit, G. Corradin, P. Vega, Eileen Franke, Stephen Hoffman (1996)
Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.Journal of immunology, 157 9
Many human T-cell responses specific for epitopes in Plasmodium falciparum have been described, but none has yet been shown to be predictive of protection against natural malaria infection 1 . Here we report a peptide-specific T-cell assay that is strongly associated with protection of humans in The Gambia, West Africa, from both malaria infection and disease. The assay detects interferon-γ-secreting CD4+ T cells specific for a conserved sequence from the circumsporozoite protein, which binds to many human leukocyte antigen (HLA)-DR types 2 . The correlation was observed using a cultured, rather than an ex vivo, ELISPOT assay that measures central memory-'type T cells rather than activated effector T cells 3,4 . These findings provide direct evidence for a protective role for CD4+ T cells in humans, and a precise target for the design of improved vaccines against P. falciparum.
Nature Medicine – Springer Journals
Published: Mar 14, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.